Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
British Journal of Cancer
|
July 3, 2003
Latest trends in cancer incidence among UK South Asians in Leicester
L K Smith, J L Botha, A Benghiat, et al.
Cancer Chemotherapy and Pharmacology
|
November 17, 2001
A phase II study of caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer
A L Thomas, K O'Byrne, L Furber, et al.
Immunology Series
|
January 1, 1990
Clinical application of hematopoietic growth factors
W P Steward, J H Scarffe, T M Dexter, et al.
Seminars in Oncology
|
October 1, 1996
Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results
W P Steward, D J Dunlop, G Dabouis, et al.
Postgraduate Medical Journal
|
July 27, 2001
Familiar drugs may prevent cancer
R A Sharma, A J Gescher, K J O'Byrne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
The importance of added albumin during continuous intravenous infusion of interleukin-2 with alpha-interferon
J Cassidy, C Poole, E Sharkie, et al.
Cancer Treatment Reports
|
February 1, 1985
Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide
A B Gasser, W P Steward, J Wagstaff, et al.
Cancer Treatment Reports
|
June 1, 1984
Etoposide infusions for treatment of metastatic lung cancer
W P Steward, N Thatcher, J M Edmundson, et al.
European Journal of Cancer Care
|
April 22, 2005
Differences in attitudes between patients with primary colorectal cancer and patients with secondary colorectal cancer: is it reflected in their willingness to participate in drug trials?
G Garcea, T Lloyd, W P Steward, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1986
A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer
D B Smith, N Thatcher, W P Steward, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
British Journal of Cancer
|
July 3, 2003
Latest trends in cancer incidence among UK South Asians in Leicester
L K Smith, J L Botha, A Benghiat, et al.
Cancer Chemotherapy and Pharmacology
|
November 17, 2001
A phase II study of caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer
A L Thomas, K O'Byrne, L Furber, et al.
Immunology Series
|
January 1, 1990
Clinical application of hematopoietic growth factors
W P Steward, J H Scarffe, T M Dexter, et al.
Seminars in Oncology
|
October 1, 1996
Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results
W P Steward, D J Dunlop, G Dabouis, et al.
Postgraduate Medical Journal
|
July 27, 2001
Familiar drugs may prevent cancer
R A Sharma, A J Gescher, K J O'Byrne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
The importance of added albumin during continuous intravenous infusion of interleukin-2 with alpha-interferon
J Cassidy, C Poole, E Sharkie, et al.
Cancer Treatment Reports
|
February 1, 1985
Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide
A B Gasser, W P Steward, J Wagstaff, et al.
Cancer Treatment Reports
|
June 1, 1984
Etoposide infusions for treatment of metastatic lung cancer
W P Steward, N Thatcher, J M Edmundson, et al.
European Journal of Cancer Care
|
April 22, 2005
Differences in attitudes between patients with primary colorectal cancer and patients with secondary colorectal cancer: is it reflected in their willingness to participate in drug trials?
G Garcea, T Lloyd, W P Steward, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1986
A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer
D B Smith, N Thatcher, W P Steward, et al.
Page
of 13